BACKGROUND:Telomere length (TL), telomerase activity (TA), and plasma amyloid-β (Aβ) levels have emerged as possible predictors of cognitive decline and dementia. OBJECTIVE: To assess the: 1) effects of two 12-week relaxation programs on TL, TA, and Aβ levels in adults with subjective cognitive decline; and 2) relationship of biomarker changes to those in cognitive function, psychosocial status, and quality of life (QOL). METHODS: Participants were randomized to a 12-week Kirtan Kriya meditation (KK) or music listening (ML) program and asked to practice 12 minutes/day. Plasma Aβ(38/40/42) and peripheral blood mononuclear cell TL and TA were measured at baseline and 3 months. Cognition, stress, sleep, mood, and QOL were assessed at baseline, 3 months, and 6 months. RESULTS: Baseline blood samples were available for 53 participants (25 KK, 28 ML). The KK group showed significantly greater increases in Aβ40 than the ML group. TA rose in both groups, although increases were significant only among those with higher practice adherence and lower baseline TA. Changes in both TL and TA varied by their baseline values, with greater increases among participants with values ≤50th percentile (ps-interaction <0.006). Both groups improved in cognitive and psychosocial status (ps ≤0.05), with improvements in stress, mood, and QOL greater in the KK group. Rising Aβ levels were correlated with gains in cognitive function, mood, sleep, and QOL at both 3 and 6 months, associations that were particularly pronounced in the KK group. Increases in TL and TA were also correlated with improvements in certain cognitive and psychosocial measures. CONCLUSION: Practice of simple mind-body therapies may alter plasma Aβ levels, TL, and TA. Biomarker increases were associated with improvements in cognitive function, sleep, mood, and QOL, suggesting potential functional relationships.
RCT Entities:
BACKGROUND: Telomere length (TL), telomerase activity (TA), and plasma amyloid-β (Aβ) levels have emerged as possible predictors of cognitive decline and dementia. OBJECTIVE: To assess the: 1) effects of two 12-week relaxation programs on TL, TA, and Aβ levels in adults with subjective cognitive decline; and 2) relationship of biomarker changes to those in cognitive function, psychosocial status, and quality of life (QOL). METHODS:Participants were randomized to a 12-week Kirtan Kriya meditation (KK) or music listening (ML) program and asked to practice 12 minutes/day. Plasma Aβ(38/40/42) and peripheral blood mononuclear cell TL and TA were measured at baseline and 3 months. Cognition, stress, sleep, mood, and QOL were assessed at baseline, 3 months, and 6 months. RESULTS: Baseline blood samples were available for 53 participants (25 KK, 28 ML). The KK group showed significantly greater increases in Aβ40 than the ML group. TA rose in both groups, although increases were significant only among those with higher practice adherence and lower baseline TA. Changes in both TL and TA varied by their baseline values, with greater increases among participants with values ≤50th percentile (ps-interaction <0.006). Both groups improved in cognitive and psychosocial status (ps ≤0.05), with improvements in stress, mood, and QOL greater in the KK group. Rising Aβ levels were correlated with gains in cognitive function, mood, sleep, and QOL at both 3 and 6 months, associations that were particularly pronounced in the KK group. Increases in TL and TA were also correlated with improvements in certain cognitive and psychosocial measures. CONCLUSION: Practice of simple mind-body therapies may alter plasma Aβ levels, TL, and TA. Biomarker increases were associated with improvements in cognitive function, sleep, mood, and QOL, suggesting potential functional relationships.
Authors: Beth E Snitz; Lisa A Weissfeld; Ann D Cohen; Oscar L Lopez; Robert D Nebes; Howard J Aizenstein; Eric McDade; Julie C Price; Chester A Mathis; William E Klunk Journal: Am J Geriatr Psychiatry Date: 2015-02-11 Impact factor: 4.105
Authors: G Stennis Watson; Brenna A Cholerton; Mark A Reger; Laura D Baker; Stephen R Plymate; Sanjay Asthana; Mark A Fishel; J Jacob Kulstad; Pattie S Green; David G Cook; Steven E Kahn; Michelle L Keeling; Suzanne Craft Journal: Am J Geriatr Psychiatry Date: 2005-11 Impact factor: 4.105
Authors: Kaleigh Filisa Roberts; Donald L Elbert; Tom P Kasten; Bruce W Patterson; Wendy C Sigurdson; Rose E Connors; Vitaliy Ovod; Ling Y Munsell; Kwasi G Mawuenyega; Michelle M Miller-Thomas; Christopher J Moran; Dewitte T Cross; Colin P Derdeyn; Randall J Bateman Journal: Ann Neurol Date: 2014-10-24 Impact factor: 10.422
Authors: Rebecca E Amariglio; J Alex Becker; Jeremy Carmasin; Lauren P Wadsworth; Natacha Lorius; Caroline Sullivan; Jacqueline E Maye; Christopher Gidicsin; Lesley C Pepin; Reisa A Sperling; Keith A Johnson; Dorene M Rentz Journal: Neuropsychologia Date: 2012-08-23 Impact factor: 3.139
Authors: John Gallacher; Anthony Bayer; Mark Fish; Janet Pickering; Sofia Pedro; Frank Dunstan; Shah Ebrahim; Yoav Ben-Shlomo Journal: Psychosom Med Date: 2009-06-24 Impact factor: 4.312
Authors: Rainbow T H Ho; Jessie S M Chan; Chong-Wen Wang; Benson W M Lau; Kwok Fai So; Li Ping Yuen; Jonathan S T Sham; Cecilia L W Chan Journal: Ann Behav Med Date: 2012-10
Authors: K E Innes; T K Selfe; C J Brown; K M Rose; A Thompson-Heisterman Journal: Evid Based Complement Alternat Med Date: 2012-02-21 Impact factor: 2.629
Authors: Sarah E Harris; Riccardo E Marioni; Carmen Martin-Ruiz; Alison Pattie; Alan J Gow; Simon R Cox; Janie Corley; Thomas von Zglinicki; John M Starr; Ian J Deary Journal: Mech Ageing Dev Date: 2016-02-10 Impact factor: 5.432
Authors: Elizabeth M Hudak; Jennifer Bugos; Ross Andel; Jennifer J Lister; Ming Ji; Jerri D Edwards Journal: Contemp Clin Trials Date: 2019-06-18 Impact factor: 2.226
Authors: Rebecca Erwin Wells; Catherine Kerr; Michelle L Dossett; Suzanne C Danhauer; Stephanie J Sohl; Bonnie C Sachs; Jacquelyn Walsh Feeley; Jennifer Wolkin; Robert Wall; Ted Kaptchuk; Daniel Z Press; Russell S Phillips; Gloria Y Yeh Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Ashley M Henneghan; Brandon G Fico; Michelle L Wright; Shelli R Kesler; Michelle L Harrison Journal: Explore (NY) Date: 2021-11-10 Impact factor: 2.358
Authors: Andrea Brioschi Guevara; Melanie Bieler; Daniele Altomare; Marcelo Berthier; Chantal Csajka; Sophie Dautricourt; Jean-François Démonet; Alessandra Dodich; Giovanni B Frisoni; Carlo Miniussi; José Luis Molinuevo; Federica Ribaldi; Philip Scheltens; Gael Chételat Journal: Alzheimers Res Ther Date: 2021-10-11 Impact factor: 6.982